TRIM9 immunoreactivity was shown to be diminished in affected brain areas in Parkinson’s disease and dementia with Lewy bodies, indicating a possible role for TRIM9 in neurodegenerative diseases[25]. Here, TRIM9 is linked to neurodegenerative disease.